Crossmark

Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries (TARGETS): study protocol for a prospective, randomized, double-blind, non-inferiority trial

Crossref DOI link: https://doi.org/10.1186/s13063-019-3231-9

Published Online: 2019-02-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hui, Shangyi

Tao, Liyuan

Mahmood, Feroze

Xu, Derong

Ren, Zhinan

Chen, Xin

Sheng, Lin

Zhuang, Qianyu https://orcid.org/0000-0003-0083-5190
Li, Shugang

Huang, Yuguang
Funding

Funding for this research was provided by:

Beijing Municipal Excellent Talents Foundation (2015000021223ZK27)
License Information

Text and Data Mining valid from 2019-02-12
More Information

Article History

Received: 20 August 2018

Accepted: 29 January 2019

First Online: 12 February 2019

Ethics approval and consent to participate

: The study protocol and consent forms were approved on 19 January 2016 by the Institutional Review Board of Peking Union Medical College Hospital. The study has been registered at ClinicalTrials.gov (NCT03011866).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below